Annual Net Income:
-$51.74M+$157.50M(+75.27%)Summary
- As of today, ESPR annual net profit is -$51.74 million, with the most recent change of +$157.50 million (+75.27%) on December 31, 2024.
- During the last 3 years, ESPR annual net income has risen by +$217.36 million (+80.77%).
- ESPR annual net income is now -384.96% below its all-time high of -$10.67 million, reached on December 31, 1999.
Performance
ESPR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$31.33M-$18.61M(-146.23%)Summary
- As of today, ESPR quarterly net profit is -$31.33 million, with the most recent change of -$18.61 million (-146.23%) on September 30, 2025.
- Over the past year, ESPR quarterly net income has dropped by -$1.81 million (-6.13%).
- ESPR quarterly net income is now -125.14% below its all-time high of $124.61 million, reached on June 30, 2020.
Performance
ESPR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$105.83M-$1.81M(-1.74%)Summary
- As of today, ESPR TTM net profit is -$105.83 million, with the most recent change of -$1.81 million (-1.74%) on September 30, 2025.
- Over the past year, ESPR TTM net income has dropped by -$19.06 million (-21.97%).
- ESPR TTM net income is now -4221.40% below its all-time high of -$2.45 million, reached on March 31, 2012.
Performance
ESPR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ESPR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +75.3% | -6.1% | -22.0% |
| 3Y3 Years | +80.8% | +43.1% | +56.5% |
| 5Y5 Years | +46.8% | +63.3% | -4.8% |
ESPR Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +80.8% | -151.3% | +49.4% | -104.5% | +56.5% |
| 5Y | 5-Year | at high | +80.8% | -151.3% | +70.0% | -104.5% | +67.4% |
| All-Time | All-Time | -385.0% | +80.8% | -125.1% | +70.0% | -4221.4% | +67.4% |
ESPR Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$31.33M(-146.2%) | -$105.83M(-1.7%) |
| Jun 2025 | - | -$12.72M(+68.5%) | -$104.02M(+32.1%) |
| Mar 2025 | - | -$40.45M(-89.8%) | -$153.22M(-196.1%) |
| Dec 2024 | -$51.74M(+75.3%) | -$21.32M(+27.8%) | -$51.74M(+40.4%) |
| Sep 2024 | - | -$29.52M(+52.3%) | -$86.77M(+11.9%) |
| Jun 2024 | - | -$61.92M(-201.5%) | -$98.50M(-13.9%) |
| Mar 2024 | - | $61.02M(+208.3%) | -$86.51M(+58.7%) |
| Dec 2023 | -$209.25M(+10.4%) | -$56.34M(-36.6%) | -$209.25M(-0.4%) |
| Sep 2023 | - | -$41.25M(+17.4%) | -$208.39M(+6.2%) |
| Jun 2023 | - | -$49.94M(+19.1%) | -$222.26M(+6.9%) |
| Mar 2023 | - | -$61.72M(-11.2%) | -$238.65M(-2.1%) |
| Dec 2022 | -$233.66M(+13.2%) | -$55.49M(-0.7%) | -$233.66M(+4.0%) |
| Sep 2022 | - | -$55.12M(+16.9%) | -$243.29M(+5.5%) |
| Jun 2022 | - | -$66.32M(-16.9%) | -$257.56M(-9.6%) |
| Mar 2022 | - | -$56.73M(+12.9%) | -$234.90M(+12.7%) |
| Dec 2021 | -$269.11M(-87.5%) | -$65.12M(+6.1%) | -$269.11M(+12.8%) |
| Sep 2021 | - | -$69.39M(-58.9%) | -$308.46M(+4.9%) |
| Jun 2021 | - | -$43.67M(+52.0%) | -$324.52M(-107.7%) |
| Mar 2021 | - | -$90.94M(+13.0%) | -$156.24M(-8.8%) |
| Dec 2020 | -$143.55M(-47.7%) | -$104.48M(-22.3%) | -$143.55M(-42.1%) |
| Sep 2020 | - | -$85.44M(-168.6%) | -$101.02M(-20.3%) |
| Jun 2020 | - | $124.61M(+259.2%) | -$83.96M(+68.1%) |
| Mar 2020 | - | -$78.25M(-26.3%) | -$262.79M(-170.5%) |
| Dec 2019 | -$97.17M(+51.9%) | -$61.95M(+9.4%) | -$97.17M(-2.0%) |
| Sep 2019 | - | -$68.38M(-26.1%) | -$95.26M(-24.0%) |
| Jun 2019 | - | -$54.22M(-162.1%) | -$76.79M(-12.4%) |
| Mar 2019 | - | $87.38M(+245.5%) | -$68.30M(+66.2%) |
| Dec 2018 | -$201.81M | -$60.04M(-20.3%) | -$201.81M(-12.3%) |
| Sep 2018 | - | -$49.91M(-9.1%) | -$179.66M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$45.73M(+0.9%) | -$174.97M(-1.4%) |
| Mar 2018 | - | -$46.13M(-21.7%) | -$172.58M(-3.3%) |
| Dec 2017 | -$166.99M(-122.7%) | -$37.89M(+16.2%) | -$166.99M(-5.7%) |
| Sep 2017 | - | -$45.22M(-4.3%) | -$158.05M(-21.4%) |
| Jun 2017 | - | -$43.34M(-6.9%) | -$130.24M(-29.0%) |
| Mar 2017 | - | -$40.54M(-40.0%) | -$100.93M(-34.6%) |
| Dec 2016 | -$74.98M(-50.6%) | -$28.96M(-66.4%) | -$74.98M(-26.8%) |
| Sep 2016 | - | -$17.40M(-24.0%) | -$59.14M(-8.4%) |
| Jun 2016 | - | -$14.04M(+3.8%) | -$54.54M(-3.1%) |
| Mar 2016 | - | -$14.59M(-11.1%) | -$52.90M(-6.3%) |
| Dec 2015 | -$49.78M(-36.9%) | -$13.12M(-2.5%) | -$49.78M(-7.9%) |
| Sep 2015 | - | -$12.80M(-3.3%) | -$46.12M(-6.9%) |
| Jun 2015 | - | -$12.39M(-8.1%) | -$43.12M(-7.9%) |
| Mar 2015 | - | -$11.47M(-21.2%) | -$39.97M(-9.9%) |
| Dec 2014 | -$36.38M(-39.4%) | -$9.46M(+3.6%) | -$36.38M(+0.6%) |
| Sep 2014 | - | -$9.81M(-6.1%) | -$36.61M(-14.3%) |
| Jun 2014 | - | -$9.24M(-17.3%) | -$32.04M(-7.8%) |
| Mar 2014 | - | -$7.87M(+18.7%) | -$29.72M(-13.9%) |
| Dec 2013 | -$26.09M(-122.2%) | -$9.69M(-85.0%) | -$26.09M(-59.1%) |
| Sep 2013 | - | -$5.24M(+24.3%) | -$16.40M(-46.9%) |
| Jun 2013 | - | -$6.92M(-63.3%) | -$11.16M(-163.3%) |
| Mar 2013 | - | -$4.24M(-73.1%) | -$4.24M(-73.1%) |
| Dec 2012 | -$11.74M(-8.5%) | - | - |
| Mar 2012 | - | -$2.45M | -$2.45M |
| Dec 2011 | -$10.82M(+62.3%) | - | - |
| Dec 2002 | -$28.73M(-15.2%) | - | - |
| Dec 2001 | -$24.93M(+9.6%) | - | - |
| Dec 2000 | -$27.58M(-158.4%) | - | - |
| Dec 1999 | -$10.67M | - | - |
FAQ
- What is Esperion Therapeutics, Inc. annual net profit?
- What is the all-time high annual net income for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. annual net income year-on-year change?
- What is Esperion Therapeutics, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. quarterly net income year-on-year change?
- What is Esperion Therapeutics, Inc. TTM net profit?
- What is the all-time high TTM net income for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. TTM net income year-on-year change?
What is Esperion Therapeutics, Inc. annual net profit?
The current annual net income of ESPR is -$51.74M
What is the all-time high annual net income for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high annual net profit is -$10.67M
What is Esperion Therapeutics, Inc. annual net income year-on-year change?
Over the past year, ESPR annual net profit has changed by +$157.50M (+75.27%)
What is Esperion Therapeutics, Inc. quarterly net profit?
The current quarterly net income of ESPR is -$31.33M
What is the all-time high quarterly net income for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high quarterly net profit is $124.61M
What is Esperion Therapeutics, Inc. quarterly net income year-on-year change?
Over the past year, ESPR quarterly net profit has changed by -$1.81M (-6.13%)
What is Esperion Therapeutics, Inc. TTM net profit?
The current TTM net income of ESPR is -$105.83M
What is the all-time high TTM net income for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high TTM net profit is -$2.45M
What is Esperion Therapeutics, Inc. TTM net income year-on-year change?
Over the past year, ESPR TTM net profit has changed by -$19.06M (-21.97%)